Latest filing published 30 Mar 2021 for Cyclo Therapeutics, Inc., €314.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Joshua M. Fine: trading record in brief
All filings by Joshua M. Fine on record concern Cyclo Therapeutics, Inc. Over a trading history stretching from 27 September 2019 to 29 March 2021, the count stands at 5 filings.
On the market, this insider has only ever bought: 3 purchases, €1,933 in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants. In 2021 alone, the filings show 1 purchase and no sales.
Half of the purchases are above €673 and half below. 1 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 30 March 2021 came the latest disclosure, an open-market purchase for €314 in Cyclo Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Joshua M. Fine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50 shares@ US$7.4016.3% of flowCommon StockSEC:0001437749-21-007618:0Canonical exit: 27 Jun 2021 (T+90)
- 10,000 shares0Common StockSEC:0001437749-21-001215:0
- 10,000 shares@ US$0.079941.6% of flowCommon StockSEC:0001437749-20-024481:0Canonical exit: 21 Feb 2021 (T+90)
- 15,000 shares@ US$0.07558.4% of flowCommon StockSEC:0001437749-20-024481:1Canonical exit: 23 Feb 2021 (T+90)
- 50,000 shares0Common StockSEC:0001437749-19-019215:0
5 of 5 declarations